In research led by a Saint Louis University investigator, molecular biologists have discovered a way to harness the enzyme thrombin’s anti-blood clotting properties. The finding opens the door to new medications that will treat diseases related to thrombosis, the presence of blood clots in blood vessels, which is responsible for nearly a third of all deaths in the U.S. “Thrombosis is one of the most prevalent causes of fatal disease,” said lead researcher Enrico Di Cera, M.D., chair of the department of biochemistry and molecular biology at Saint Louis University School of Medicine…

Read more here: 
Investigators Perfect New Version Of Blood-Regulator Thrombin

You may also like:

• Children, Elderly Most Vulnerable To Soaring Summer Temperatures
• Women Who Consume Large Amounts Of Tea Have Increased Risk Of Rheumatoid Arthritis
• SAHM Strongly Recommends Human Papillomavirus Vaccination For 9- To 26-Year-Old Males
• Aerobic Activity May Keep The Brain Young
• Sleep Apnea Thickens Blood Vessels, Increases Heart Disease Risk
• NICE Consults On Draft Recommendations For Psychosis With Co-Existing Substance Misuse
• NICE Consults On Draft Guideline On Food Allergies In Children
• GPs Failing To Diagnose Dementia Early
• K-State Professor’s Research Gets Boost From National Institutes Of Health
• Hotspur Technologies Receives FDA 510(k) Clearance For First Three Product Lines Based On The Company’s Unique Technology